Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with 18F-FDG PET/CT (Q92707314)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 March 2019

edit

Language	Label	Description	Also known as
English	Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with 18F-FDG PET/CT	scientific article published on 29 March 2019

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30926649

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30926649%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 May 2020

title

Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with 18F-FDG PET/CT (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

main subject

prostate cancer

1 reference

based on heuristic

inferred from title

Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography

1 reference

based on heuristic

inferred from title

author name string

Hossein Jadvar

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

Erik M Velez

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

Bhushan Desai

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

Lingyun Ji

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

Patrick M Colletti

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

David I Quinn

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

language of work or name

English

0 references

publication date

29 March 2019

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30926649

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30926649%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 May 2020

published in

The Journal of Nuclear Medicine

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

volume

60

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

issue

11

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

page(s)

1524-1530

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

cites work

225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Cancer statistics, 2018.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

The Diagnosis and Treatment of Prostate Cancer: A Review

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Is There Use for FDG-PET in Prostate Cancer?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Positron Emission Tomography in Prostate Cancer: Summary of Systematic Reviews and Meta-Analysis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Serum follicle-stimulating hormone levels predict time to development of castration-resistant prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Risk Stratification in Hormone-sensitive Metastatic Prostate Cancer: More Questions than Answers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Intermittent versus continuous androgen deprivation in prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Molecular imaging of prostate cancer: PET radiotracers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Characterising the castration-resistant prostate cancer population: a systematic review

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

FDG PET in Prostate Cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

FDG PET in suspected recurrent and metastatic prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6836859

retrieved

11 February 2021

Identifiers

DOI

10.2967/JNUMED.118.223263

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

PMC publication ID

6836859

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

PubMed publication ID

30926649

1 reference

stated in

Europe PubMed Central

PMC publication ID

6836859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6836859&resulttype=core&format=json

retrieved

12 May 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q92707314&oldid=2246416321"